...Dako received FDA clearance to market its TOP2A FISH pharmDx genetic test to assess the risk of tumor...
...increased likelihood of tumor recurrence or decreased long-term survival. Dako A/S , Glostrup, Denmark Product: TOP2A FISH pharmDx...

...FDA approved the TOP2A FISH pharmDx genetic test from Dako (Glostrup, Denmark) to assess the risk of tumor...